Current
32.0×
5-Year Average
23.3×
All-Time High
33.3×
All-Time Low
10.4×
P/FCF Ratio daily chart for Johnson & Johnson (JNJ)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
P/FCF ratio is not shown for periods when TTM free cash flow was negative.
Historical P/FCF Ratio for Johnson & Johnson (JNJ) from 2001 to 2025
| 2025 | $504.08B | $19.70B | 25.6× | +6.5× | |
| 2024 | $345.01B | $18.06B | 19.1× | -1.6× | |
| 2023 | $377.30B | $18.25B | 20.7× | -6.2× | |
| 2022 | $461.69B | $17.18B | 26.9× | +4.1× | |
| 2021 | $449.74B | $19.76B | 22.8× | +2.2× | |
| 2020 | $414.30B | $20.19B | 20.5× | +1.2× | |
| 2019 | $384.00B | $19.92B | 19.3× | +0.3× | |
| 2018 | $351.53B | $18.53B | 19.0× | -2.1× | |
| 2017 | $375.13B | $17.78B | 21.1× | +1.0× | |
| 2016 | $311.82B | $15.54B | 20.1× | +2.2× | |
| 2015 | $283.01B | $15.82B | 17.9× | -1.8× | |
| 2014 | $291.04B | $14.76B | 19.7× | +1.0× | |
| 2013 | $258.34B | $13.82B | 18.7× | +3.1× | |
| 2012 | $194.77B | $12.46B | 15.6× | -0.1× | |
| 2011 | $178.94B | $11.40B | 15.7× | +3.6× | |
| 2010 | $169.65B | $14.00B | 12.1× | -0.4× | |
| 2009 | $177.64B | $14.21B | 12.5× | -1.4× | |
| 2008 | $165.99B | $11.91B | 13.9× | -2.0× | |
| 2007 | $190.47B | $11.94B | 16.0× | -0.8× | |
| 2006 | $192.28B | $11.51B | 16.7× | -2.7× | |
| 2005 | $179.39B | $9.24B | 19.4× | -1.6× | |
| 2004 | $188.24B | $8.96B | 21.0× | +2.6× | |
| 2003 | $153.33B | $8.33B | 18.4× | -7.9× | |
| 2002 | $159.73B | $6.08B | 26.3× | +1.1× | |
| 2001 | $179.37B | $7.13B | 25.1× | — |
- 202525.6×
- 202419.1×
- 202320.7×
- 202226.9×
- 202122.8×
- 202020.5×
- 201919.3×
- 201819.0×
- 201721.1×
- 201620.1×
- 201517.9×
- 201419.7×
- 201318.7×
- 201215.6×
- 201115.7×
- 201012.1×
- 200912.5×
- 200813.9×
- 200716.0×
- 200616.7×
- 200519.4×
- 200421.0×
- 200318.4×
- 200226.3×
- 200125.1×
About P/FCF Ratio at Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) P/FCF ratio is 32.0× as of June 5, 2026. The 5-year average is 23.3×. The sector median currently stands at 19.8×. The current ratio is at the 100th percentile of its own 10-year history.
Johnson & Johnson (JNJ) historical P/FCF ratio has ranged from a low of 10.4× (2010) to a high of 33.3× (2026) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Johnson & Johnson P/FCF Ratio by Year
Johnson & Johnson P/FCF Ratio 2025: 25.6×
Johnson & Johnson (JNJ) P/FCF ratio in 2025 was 25.6×, expanded from 19.1× the prior year.
Johnson & Johnson P/FCF Ratio 2024: 19.1×
Johnson & Johnson (JNJ) P/FCF ratio in 2024 was 19.1×, contracted from 20.7× the prior year.
Johnson & Johnson P/FCF Ratio 2023: 20.7×
Johnson & Johnson (JNJ) P/FCF ratio in 2023 was 20.7×, contracted from 26.9× the prior year.
Johnson & Johnson P/FCF Ratio 2022: 26.9×
Johnson & Johnson (JNJ) P/FCF ratio in 2022 was 26.9×, expanded from 22.8× the prior year.
Johnson & Johnson P/FCF Ratio 2021: 22.8×
Johnson & Johnson (JNJ) P/FCF ratio in 2021 was 22.8×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Johnson & Johnson (JNJ), ranked by P/FCF ratio.
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric